BioROSA Technologies

0 followers


BioROSA is developing a highly accurate blood test that will detect ASD in children as young as 18 months. At BioROSA Technologies, they want to make the diagnosis of Autism Spectrum disorder (ASD) rapid and simple.

Industries

Headquarters

Employees

Links

Org chart

John Slattery
Co-Founder, CEO

John Slattery

Collapse
Marie Causey
Co-Founder, CSO
Ian Eliason
Investor & Advisor